Morgan Stanley Maintains Equal-Weight on Zimmer Biomet Holdings, Lowers Price Target to $120
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Cecilia Furlong maintains an Equal-Weight rating on Zimmer Biomet Holdings (NYSE:ZBH) but lowers the price target from $130 to $120.
July 15, 2024 | 4:56 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley has maintained its Equal-Weight rating on Zimmer Biomet Holdings but has lowered the price target from $130 to $120.
The lowered price target from $130 to $120 by Morgan Stanley suggests a less optimistic outlook for Zimmer Biomet Holdings, which could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100